Related Experiment Video
Updated: Feb 12, 2026

Two-Dimensional X-Ray Angiography to Examine Fine Vascular Structure Using a Silicone Rubber Injection Compound
Published on: January 7, 2019
Injectable silicone rubber for ocular implantation after evisceration
Peng Fei Zheng1,2, Qi Sheng You2, Qian Li1
1Department of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Addition type liquid silicone rubber (ATLSR) is a viable injectable implant for maintaining eyeball volume after evisceration. This biocompatible material demonstrated cosmetic satisfaction and spontaneous inflammation regression in animal studies.
Area of Science:
- Ophthalmology
- Biomaterials Science
- Veterinary Medicine
Background:
- Evisceration is a surgical procedure to remove the eye's contents while preserving the sclera.
- Maintaining orbital volume post-evisceration is crucial for cosmetic outcomes and prosthesis fitting.
- Current orbital implants may have limitations in terms of biocompatibility and ease of insertion.
Purpose of the Study:
- To evaluate the efficacy of addition type liquid silicone rubber (ATLSR) as an injectable implant for maintaining eyeball volume after evisceration in an animal model.
- To assess the biocompatibility and inflammatory response to ATLSR implants over a 24-week period.
Main Methods:
- Twelve New Zealand white rabbits underwent evisceration of one eye, with the fellow eye serving as a control.
- ATLSR was injected into the eviscerated sockets to serve as an implant.
- In vivo observations, photographic documentation, and post-operative measurements of ocular dimensions were conducted up to 24 weeks.
- Histopathological analysis was performed to assess inflammation and tissue response.
Main Results:
- ATLSR implants maintained ocular volume, showing significant differences in sagittal and vertical diameters compared to control eyes.
- Corneal clarity was maintained, with only mild epithelial edema and neovascularization observed.
- Initial post-operative inflammation peaked at 2-3 weeks but gradually regressed, with minimal inflammatory cells remaining by 24 weeks.
Conclusions:
- Injectable ATLSR is a promising option for ocular implantation post-evisceration, effectively maintaining eyeball volume and providing satisfactory cosmetic results.
- The spontaneous regression of inflammation suggests good biocompatibility of ATLSR for at least 24 weeks.
- ATLSR offers a potentially advantageous alternative for orbital reconstruction due to its injectable nature and demonstrated safety profile.
Related Concept Videos
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Gas Chromatography: Sample Injection Systems
Two primary injection methods are used...
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Reproductive Cloning
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic...
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...

